Icon (ICLR) Stock Forecast & Price Target

$121.32 +9.35 (+8.35%)

Closing price 05/5/2026 04:00 PM Eastern

Extended Trading

$121.06 -0.26 (-0.22%)

As of 05/5/2026 07:59 PM Eastern

Compare

Icon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 15 Analyst Ratings

Sell
3

Hold
5

Buy
7

Based on 15 Wall Street analysts who have issued ratings for Icon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 3 have given a sell rating, 5 have given a hold rating, and 7 have given a buy rating for ICLR.

Consensus Price Target

$149.38
23.13% Upside

According to the 15 analysts' twelve-month price targets for Icon, the average price target is $149.38. The highest price target for ICLR is $240.00, while the lowest price target for ICLR is $75.00. The average price target represents a forecasted upside of 23.13% from the current price of $121.32.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ICLR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Icon and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICLR Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)
Hold	5 Hold rating(s)	7 Hold rating(s)	11 Hold rating(s)	6 Hold rating(s)
Sell	3 Sell rating(s)	3 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$149.38	$148.80	$200.60	$215.33
Forecasted Upside	23.13% Upside	35.74% Upside	37.97% Upside	59.39% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

ICLR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ICLR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Icon Stock vs. The Competition

Type	Icon	Medical Companies	S&P 500
Consensus Rating Score	2.27	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	23.13% Upside	938.23% Upside	14.74% Upside
News Sentiment Rating	Positive News See Recent ICLR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/4/2026	Leerink Partners 2 of 5 stars	Michael Cherny Not Rated	Set Target		$125.00	+10.77%
3/26/2026	BMO Capital Markets 4 of 5 stars	Sean Dodge Not Rated	Upgrade	Market Perform ➝ Outperform	$100.00 ➝ $130.00	+30.01%
3/18/2026	Weiss Ratings Not Rated		Downgrade	Hold (C-) ➝ Sell (D+)
3/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Donnelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$200.00 ➝ $120.00	+14.55%
3/9/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$200.00 ➝ $120.00	+14.16%
2/25/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold ➝ Strong Sell
2/23/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Hold ➝ Buy	$175.00 ➝ $135.00	+35.41%
2/18/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Rhyee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$183.00 ➝ $120.00	+35.41%
2/17/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy ➝ Neutral	$100.00	+7.53%
2/13/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Coldwell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$119.00	+26.96%

2/12/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral ➝ Underperform	$75.00	-43.67%
1/9/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$216.00	+14.76%
1/8/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$231.00 ➝ $222.00	+9.40%
10/24/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Sourbeer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$220.00	+24.89%
7/25/2025	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Muken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$170.00 ➝ $240.00	+28.37%
5/2/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	M. Sykes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$180.00 ➝ $160.00	+9.30%
4/29/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$265.00 ➝ $150.00	+3.45%
1/15/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Dodge Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$263.00 ➝ $263.00	+29.67%
1/14/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Smock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:28 AM ET.

Should I Buy Icon Stock? ICLR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, May 1, 2026. Please send any questions or comments about these Icon pros and cons to contact@marketbeat.com.

Icon
Bull Case

Here are some ways that investors could benefit from investing in ICON Public Limited:

The current stock price is around $119, which reflects a significant increase from its twelve-month low of $66.57, indicating potential growth opportunities.
ICON Public Limited has received multiple "Buy" ratings from analysts, suggesting strong confidence in the company's future performance.
The company has a solid market capitalization of approximately $9.67 billion, which positions it well within the industry and provides stability.
With a debt-to-equity ratio of 0.31, ICON Public Limited demonstrates a strong balance sheet, indicating lower financial risk and better capacity to manage debt.
Recent upgrades in ratings and price targets from various financial institutions highlight positive market sentiment and potential for further appreciation in stock value.

Icon
Bear Case

Investors should be bearish about investing in ICON Public Limited for these reasons:

Some analysts have issued "underperform" ratings, with a price target as low as $75, indicating concerns about the company's future performance.
The stock has a relatively high price-to-earnings (P/E) ratio of 16.19, which may suggest that it is overvalued compared to its earnings potential.
Despite recent positive movements, the stock has experienced volatility, with a significant difference between its twelve-month high of $211 and its current price.
Market analysts have mixed opinions, with an average rating of "Hold," suggesting uncertainty about the stock's future trajectory.
ICON Public Limited operates in a competitive industry, which may pose challenges in maintaining market share and profitability against rivals.

ICLR Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Icon is $149.38, with a high forecast of $240.00 and a low forecast of $75.00.
: 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Icon in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ICLR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICLR, but not buy additional shares or sell existing shares.
: According to analysts, Icon's stock has a predicted upside of 23.13% based on their 12-month stock forecasts.
: Over the previous 90 days, Icon's stock had 3 upgrades and 3 downgrades by analysts.
: Icon has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, Citigroup, Jefferies Financial Group, Leerink Partners, Robert W. Baird, Rothschild & Co Redburn, TD Cowen, Weiss Ratings, and Zacks Research in the past 90 days.
: Analysts like Icon less than other "medical" companies. The consensus rating score for Icon is 2.27 while the average consensus rating score for "medical" companies is 2.30. Learn more on how ICLR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Icon Recommendations

This page (NASDAQ:ICLR) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Icon (ICLR) Stock Forecast & Price Target

Icon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ICLR Analyst Ratings Over Time

ICLR Analyst Recommendations By Month

ICLR Price Targets by Month

Icon Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Icon Stock? ICLR Pros and Cons Explained

Icon
Bull Case

Icon
Bear Case

ICLR Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Icon Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Icon (ICLR) Stock Forecast & Price Target

Icon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ICLR Analyst Ratings Over Time

ICLR Analyst Recommendations By Month

ICLR Price Targets by Month

Icon Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Icon Stock? ICLR Pros and Cons Explained

Icon Bull Case

Icon Bear Case

ICLR Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Icon Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Icon
Bull Case

Icon
Bear Case